Icon (ICLR) Net Income towards Common Stockholders (2009 - 2026)
Icon's (ICLR) quarterly Net Income towards Common Stockholders came in at $198.4 million in Q2 2026, down 29.22% year-over-year from $280.3 million in Q2 2025, and up 31.95% quarter-over-quarter from $150.4 million in Q1 2026.
Analysis
Icon (ICLR) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Net Income towards Common Stockholders for 18 consecutive years, with $198.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 29.22% year-over-year to $198.4 million in Q2 2026; TTM through Jun 2026 was $778.1 million, a 29.28% decrease from a year earlier, with the FY2025 full-year figure at $873.4 million, down 24.88% from the prior year.
- Net Income towards Common Stockholders was $198.4 million for Q2 2026 at Icon, up from $150.4 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $312.6 million in Q2 2024 and troughed at $139.3 million in Q1 2022.
- A 5-year average of $234.7 million and a median of $256.1 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders surged 301.75% in 2022 and slumped 41.78% in 2026, its largest moves.
- Over 5 years, Net Income towards Common Stockholders stood at $257.7 million in 2022, then decreased by 1.23% to $254.6 million in 2023, then grew by 10.95% to $282.4 million in 2024, then tumbled by 39.63% to $170.5 million in 2025, then rose by 16.36% to $198.4 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $198.4 million (Q2 2026), $150.4 million (Q1 2026), and $170.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 241.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 121.36 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 198.40 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -760,000.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -13.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -46.71 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -426,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -4.28 Bn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 198.40 Mn |
| Mar 31, 2026 | 150.37 Mn |
| Dec 31, 2025 | 170.51 Mn |
| Sep 30, 2025 | 258.80 Mn |
| Jun 30, 2025 | 280.31 Mn |
| Mar 31, 2025 | 258.27 Mn |
| Dec 31, 2024 | 282.42 Mn |
| Sep 30, 2024 | 279.21 Mn |
| Jun 30, 2024 | 312.59 Mn |
| Mar 31, 2024 | 288.51 Mn |
| Dec 31, 2023 | 254.56 Mn |
| Sep 30, 2023 | 264.27 Mn |
| Jun 30, 2023 | 249.34 Mn |
| Mar 31, 2023 | 232.27 Mn |
| Dec 31, 2022 | 257.73 Mn |
| Sep 30, 2022 | 203.18 Mn |
| Jun 30, 2022 | 145.10 Mn |
| Mar 31, 2022 | 139.33 Mn |
| Dec 31, 2021 | 106.39 Mn |
| Sep 30, 2021 | -100.71 Mn |